Related references
Note: Only part of the references are listed.The Long-term Effects of Metformin on Patients With Type 2 Diabetic Kidney Disease
Soie Kwon et al.
DIABETES CARE (2020)
Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or 4
Jean-Daniel Lalau et al.
DIABETES CARE (2018)
Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study
Clara K. Chow et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Pharmacokinetics of metformin in patients with chronic kidney disease stage 4 and metformin-naive type 2 diabetes
Ajith M. Dissanayake et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2018)
Metformin-associated lactic acidosis: Current perspectives on causes and risk
Ralph DeFronzo et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
METFORMIN IN CHRONIC KIDNEY DISEASE: TIME FOR A RETHINK
James Heaf
PERITONEAL DIALYSIS INTERNATIONAL (2014)
Mortality rate in so-called metformin-associated lactic acidosis: a review of the data since the 1960s
Farshad Kajbaf et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2014)
Metformin in renal failure-weigh the evidence
M. Krishna Mani
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Contraindications to metformin therapy among patients with type 2 diabetes mellitus
Waleed M. Sweileh
PHARMACY WORLD & SCIENCE (2007)
Metformin and lactic acidosis: cause or coincidence? A review of case reports
AME Stades et al.
JOURNAL OF INTERNAL MEDICINE (2004)
Share Paper
